Skip to content
MarketScale
Demo
‹ Back to IndustriesHealthcare

How AI and Automation is Changing Healthcare

Terms like Artificial Intelligence (AI) and automation tend to cause two reactions: trepidation or excitement. And while AI and automation have undoubtedly blended into popular culture as tenets of sci-fi and dystopian futures, AI and automation should evoke more excitement rather than fear for what they can bring to our futures, especially in healthcare. So,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
How AI and Automation is Changing Healthcare

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Terms like Artificial Intelligence (AI) and automation tend to cause two reactions: trepidation or excitement. And while AI and automation have undoubtedly blended into popular culture as tenets of sci-fi and dystopian futures, AI and automation should evoke more excitement rather than fear for what they can bring to our futures, especially in healthcare.

So, how is AI transforming the future of healthcare?

On the latest episode of the Healthcare ReThink podcast, host Brian Urban discusses the game-changing technology being introduced to healthcare with Co-Founder and COO of CloudMedx, Sahar Arshad.

The two discuss:

  • How AI is unifying the healthcare system
  • How CloudMedx uses AI and automation to improve operations and clinical outcomes
  • How AI and automation is being adopted throughout the healthcare industry

“There’s a lot of opportunity to grow in places where it can really elevate the experience for everyone—patients, providers, payers. The experience is very, very broken, right? For a patient, there’s long wait times, there’s you don’t know how much a procedure would cost, it’s just a lot of confusion, and similarly with physicians it’s the same problem, lots of documentation and administrative work…” said Arshad.

Sahar Arshad is the Co-Founder and COO of CloudMedx, a healthcare data aggregation company that puts data into a single unified platform. She has over 20 years of experience in building products that bring convenience and accessibility at scale. Prior to founding CloudMedx, Arshad worked as a woman in tech in various roles, including as a Business Analyst for Inbox Business Technologies and as the CEO of Imaginate Technologies.

She has been awarded numerous industry awards, including selection as a U. S. Data Leader of the Year and U.

S. Entrepreneur of the Year at the 2021 Women in IT Summit and Awards Series. She has also been named among the top 10 women leading healthcare startups by Healthcare Global and within the top 25 women leaders in consumer health tech by the Healthcare Technology Report.

She earned her BS in Computer Science from the National University of Computer and Emerging Sciences.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For Healthcare teams

See how Healthcare teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›Marketing Tech›
Keep exploring

More from Healthcare

Healthcare hubMore expert Healthcare coverage.Explore →Executive Thought LeadershipPut clinical leaders on the record.Explore →CooperVisionMedical device storytelling.Explore →State of GEO & AI VisibilityHow B2B brands get cited by AI search.Explore →

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512